-
Je něco špatně v tomto záznamu ?
Analysis of Salivary Neuropeptides in Anxiety and Depression Using the Luminex MAGPIX® System
I. Kupcova, L. Danisovic, S. Bernatova, S. Harsanyi
Status neindexováno Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
PubMed Central
od 2012
Europe PubMed Central
od 2015
ProQuest Central
od 2012-01-01
Open Access Digital Library
od 2012-01-01
Open Access Digital Library
od 2015-01-01
Health & Medicine (ProQuest)
od 2012-01-01
PubMed
39347144
DOI
10.7759/cureus.67984
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Anxiety and depressive disorders are highly prevalent mental health conditions, affecting millions worldwide. Advancements in neurobiology have identified the effects of various neuropeptides in modulating mood and stress responses. Some of the well-researched neuropeptides in plasma are oxytocin (OXT), alpha-melanocyte-stimulating hormone (alpha-MSH), beta-endorphin, neurotensin, and substance P. In this study, we used methods of liquid biopsy to acquire saliva samples to analyze the concentrations of neuropeptides associated with depression. METHODS: The study was conducted in Bratislava, Slovakia, from January to June 2022. Participants were 20 subjects treated for depression and anxiety without medication; the control group consisted of 20 healthy individuals with no personal history of depression or anxiety. Salivary samples were collected using buccal swabs to measure the concentrations of the examined neuropeptides. Laboratory analysis was based on detecting fluorescent signals performed on the Luminex MAGPIX® System (Luminex Corporation, Austin, Texas). Means and standard deviations were calculated for individual neuropeptide levels. To determine if there are statistically significant differences in neuropeptide levels between individuals with and without depression, independent t-tests and a one-way ANOVA were conducted. RESULTS: Our findings indicate a significant decrease in all studied neuropeptides in subjects compared to healthy controls. Reductions in mean levels were observed for OXT (7.3), alpha-MSH (3.9), beta-endorphin (2.9), neurotensin (15.1), and a 6.9-fold decrease for substance P. Alpha-MSH and beta-endorphin showed higher variability in measured levels within both groups. CONCLUSION: The results of this study indicate that the levels of the studied salivary neuropeptides, OXT, alpha-MSH, beta-endorphin, neurotensin, and substance P, are statistically significantly reduced in individuals with depression compared to healthy controls.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24017946
- 003
- CZ-PrNML
- 005
- 20241016082003.0
- 007
- ta
- 008
- 241008s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.7759/cureus.67984 $2 doi
- 035 __
- $a (PubMed)39347144
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kupcova, Ida $u Institute of Medical Biology, Genetics, and Clinical Genetics, Faculty of Medicine, Comenius University Bratislava, Bratislava, SVK $u Department of Psychiatry, Psychiatric Clinic, The University Hospital Brno, Brno, CZE
- 245 10
- $a Analysis of Salivary Neuropeptides in Anxiety and Depression Using the Luminex MAGPIX® System / $c I. Kupcova, L. Danisovic, S. Bernatova, S. Harsanyi
- 520 9_
- $a BACKGROUND: Anxiety and depressive disorders are highly prevalent mental health conditions, affecting millions worldwide. Advancements in neurobiology have identified the effects of various neuropeptides in modulating mood and stress responses. Some of the well-researched neuropeptides in plasma are oxytocin (OXT), alpha-melanocyte-stimulating hormone (alpha-MSH), beta-endorphin, neurotensin, and substance P. In this study, we used methods of liquid biopsy to acquire saliva samples to analyze the concentrations of neuropeptides associated with depression. METHODS: The study was conducted in Bratislava, Slovakia, from January to June 2022. Participants were 20 subjects treated for depression and anxiety without medication; the control group consisted of 20 healthy individuals with no personal history of depression or anxiety. Salivary samples were collected using buccal swabs to measure the concentrations of the examined neuropeptides. Laboratory analysis was based on detecting fluorescent signals performed on the Luminex MAGPIX® System (Luminex Corporation, Austin, Texas). Means and standard deviations were calculated for individual neuropeptide levels. To determine if there are statistically significant differences in neuropeptide levels between individuals with and without depression, independent t-tests and a one-way ANOVA were conducted. RESULTS: Our findings indicate a significant decrease in all studied neuropeptides in subjects compared to healthy controls. Reductions in mean levels were observed for OXT (7.3), alpha-MSH (3.9), beta-endorphin (2.9), neurotensin (15.1), and a 6.9-fold decrease for substance P. Alpha-MSH and beta-endorphin showed higher variability in measured levels within both groups. CONCLUSION: The results of this study indicate that the levels of the studied salivary neuropeptides, OXT, alpha-MSH, beta-endorphin, neurotensin, and substance P, are statistically significantly reduced in individuals with depression compared to healthy controls.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Danisovic, Lubos $u Institute of Medical Biology, Genetics, and Clinical Genetics, Faculty of Medicine, Comenius University Bratislava, Bratislava, SVK
- 700 1_
- $a Bernatova, Sona $u Institute of Medical Biology, Genetics, and Clinical Genetics, Faculty of Medicine, Comenius University Bratislava, Bratislava, SVK
- 700 1_
- $a Harsanyi, Stefan $u Institute of Medical Biology, Genetics, and Clinical Genetics, Faculty of Medicine, Comenius University Bratislava, Bratislava, SVK
- 773 0_
- $w MED00207102 $t Curēus $x 2168-8184 $g Roč. 16, č. 8 (2024), s. e67984
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39347144 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241008 $b ABA008
- 991 __
- $a 20241016081958 $b ABA008
- 999 __
- $a ok $b bmc $g 2196415 $s 1229897
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 16 $c 8 $d e67984 $e 20240828 $i 2168-8184 $m Curēus $n Cureus $x MED00207102
- LZP __
- $a Pubmed-20241008